Insulin pump therapy vs. multiple daily injections in obese Type 2 diabetic patients
Authors:
- 13 July 2005
- journal article
- clinical trial
- Published by Wiley in Diabetic Medicine
- Vol. 22 (8) , 1037-1046
Abstract
Aims To compare the efficacy of insulin pump treatment with multiple daily injections in the treatment of poorly controlled obese Type 2 diabetic patients already receiving two or more daily injections of insulin plus metformin.Methods Forty obese Type 2 diabetic subjects (using insulin) were randomized to treatment with continuous subcutaneous infusion pump (CSII) (Minimed®) or multiple daily insulin injections (MDI). At the end of the first 18‐week treatment period, patients underwent a 12‐week washout period during which they were treated with MDI plus metformin. They were then crossed‐over to the other treatment for an 18‐week follow‐up period. Patients performed 4‐point daily self blood‐glucose monitoring (SBGM) on a regular basis and 7‐point monitoring prior to visits 2, 8, 10 and 16. A subset of patients underwent continuous glucose monitoring using the Minimed® continuous glucose monitoring system (CGMS) at visits 2, 8, 10 and 16. A standard meal test was performed in which serum glucose was tested at fasting and once each hour for 6 h following a test meal. Glucose levels were plotted against time and the area under the curve (AUC) was calculated. HbA1c, weight, daily insulin dose and hypoglycaemic episodes were recorded.Results In obese Type 2 diabetic patients already treated with insulin, treatment with CSII significantly reduced HbA1c levels compared with treatment with MDI. An additional CSII treatment benefit was demonstrated by reduced meal‐test glucose AUC. Initial reduction of daily insulin requirement observed in CSII‐treated subjects during the first treatment period was attributable to a period effect and did not persist over time.Conclusions In the intent‐to‐treat analysis, CSII appeared to be superior to MDI in reducing HbA1c and glucose AUC values without significant change in weight or insulin dose in obese, uncontrolled, insulin‐treated Type 2 diabetic subjects.Keywords
This publication has 18 references indexed in Scilit:
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)The Lancet, 1998
- Effect of Obesity on the Response to Insulin Therapy in Noninsulin-Dependent Diabetes MellitusThe Journal of Clinical Endocrinology & Metabolism, 1997
- Medical Hazards of ObesityAnnals of Internal Medicine, 1993
- Intensive Conventional Insulin Therapy for Type II Diabetes: Metabolic effects during a 6-mo outpatient trialDiabetes Care, 1993
- Comparison of Insulin Regimens in Patients with Non-Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1992
- Insulin Use in NIDDMDiabetes Care, 1990
- Evening Insulin StrategyDiabetes Care, 1990
- Different effects of insulin and oral antidiabetic agents on glucose and energy metabolism in Type 2 (non-insulin-dependent) diabetes mellitusDiabetologia, 1989
- The Effect of Insulin Treatment on Insulin Secretion and Insulin Action in Type II Diabetes MellitusDiabetes, 1985
- Diabetes and cardiovascular risk factors: the Framingham study.Circulation, 1979